Patent: 10,295,534
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 10,295,534
Title: | Method for measuring anti-drug antibody |
Abstract: | Provided is a method for measuring anti-drug antibodies ADAs appearing in a patient receiving molecular-targeted therapy in a simpler and more accurate manner. |
Inventor(s): | Kashiwagi; Nobuhito (Takasaki, JP), Saitoh; Fumio (Takasaki, JP), Kaneda; Kenta (Takasaki, JP), Maegawa; Hidetaka (Takasaki, JP), Yagihashi; Yuko (Takasaki, JP) |
Assignee: | JIMRO CO., LTD. (Takasaki-shi, JP) |
Application Number: | 15/498,930 |
Patent Claims: | see list of patent claims |
Details for Patent 10,295,534
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2036-04-27 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 12/31/2002 | ⤷ Try a Trial | 2036-04-27 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 02/21/2008 | ⤷ Try a Trial | 2036-04-27 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 04/24/2013 | ⤷ Try a Trial | 2036-04-27 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 09/23/2014 | ⤷ Try a Trial | 2036-04-27 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 11/23/2015 | ⤷ Try a Trial | 2036-04-27 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |